Skip to main content
Temerty Faculty of Medicine
Search this site
Menu
May 27, 2025

Canadian scientists develop blood test to quickly predict risk of sepsis

Dos Santos 2025-05-27

A team of scientists from across Canada has developed an innovative molecular-based blood test and portable device to quickly predict the risk of sepsis over the first 24 hours of clinical presentation. READ MORE

A research paper describing the test and its development was published in Nature Communications. It represents a major milestone in the way doctors will evaluate and treat sepsis. The study was the result of a collaboration between three multi-disciplinary teams. Dr. Pamela Plant and Dr. Claudia dos Santos at St. Michael’s Hospital/Unity Health Toronto, Dr. Robert Hancock at the University of British Columbia and Dr. Peter Zhang at Sepset Inc., and Dr. Lidija Malic and Dr. Teodor Veres at the National Research Council of Canada’s (NRC) Medical Devices Research Centre.

Dr. dos Santos had been a McLaughlin Centre Accelerator Grantee in 2015 and 2021.

News

Jun 26, 2026

Holland Bloorview and SickKids granted up to USD $17.25 million international research grant

Aligning Research to Impact Autism (ARIA) Funding supports Canadian-led autism and neurodevelopmental research.
May 13, 2026

Non-coding gene linked to core social and behavioural traits in autism: Toronto study

Findings help separate the biology of core Autism Spectrum Disorder (ASD) traits from cognitive impairment and show that this non-coding gene plays a distinct role in ASD biology.
Apr 29, 2026

Remembering J. Craig Venter, PhD

Dr. Venter was a visionary scientific leader whose work helped define modern genomics and launch the field of synthetic biology. He drove scientific and technological change by building interdisciplinary teams, pushing for bold ideas and faster methods, insisting that discovery should translate into real-world impact.